Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;117:131-133
doi: 10.1161/CIRCULATIONAHA.107.745026
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Callahan, T. D.
Right arrow Articles by Natale, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Callahan, T. D.
Right arrow Articles by Natale, A.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Arrhythmia
Related Collections
Right arrow Ablation/ICD/surgery
Right arrow Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2008;117:131-133.)
© 2008 American Heart Association, Inc.


Editorial

Procedural End Points in Pulmonary Vein Antrum Isolation

Are We There Yet?

Thomas D. Callahan, MD; Andrea Natale, MD

From Cardiac Electrophysiology and Pacing, Cleveland Clinic, Cleveland, Ohio (T.D.C.), and Electrophysiology Section, Department of Cardiology, Stanford University, Stanford, Calif (A.N.).

Correspondence to Andrea Natale, MD, Adjunct Professor, Section of Electrophysiology, Department of Cardiology, Stanford University Hospital, 300 Pasteur Dr, Stanford, CA 94305. E-mail nataleam@roadrunner.com


Key Words: Editorials • arrhythmia • catheter ablation • fibrillation • tachyarrhythmias


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

If you have ever been on a long car trip with a small child, you have almost certainly encountered the age-old question, "Are we there yet?" Although a careful review of the literature reveals surprisingly little in the way of rigorous studies on this matter, strong anecdotal evidence suggests that the longer or more arduous the journey and the more desirable the destination, the more likely it is this question will be asked. In our quest to develop a cure for atrial fibrillation (AF) with our catheters, electrophysiologists have found ourselves asking the very same question. This is no surprise, because the journey has been difficult, with long, technically demanding procedures, and the destination, the cure of a disease with often profound symptoms and morbidity that affects millions, is coveted. In the world of pulmonary vein antrum isolation (PVAI), what we are really asking is whether our lesions will provide our patients with a lasting cure of their AF: "Are we there yet?"

Article p 136

Unfortunately, the answer to this question has not come easily. AF is notoriously sporadic. Just because a patient’s AF is gone one moment does not mean it will not return the next. No imaging or serological testing can yet identify or rule out the heart’s propensity to develop this arrhythmia. Instead, we must hunt for surrogates to tell us whether or not we have adequately diminished the ability of a patient’s heart to develop AF. Here again, though, the questions and their answers are . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
EuropaceHome page
E. Buch and K. Shivkumar
Exploring the potential of pulmonary vein recordings: can they help elucidate mechanisms of paroxysmal atrial fibrillation?
Europace, June 1, 2008; 10(6): 690 - 691.
[Full Text] [PDF]